LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy

BACKGROUND: Low molecular weight protein tyrosine phosphatase (LMW-PTP) is overexpressed in different cancer types and its expression is related to more aggressive disease, reduced survival rate and drug resistance. Morin is a natural polyphenol which negatively modulates, among others, the activity...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Cell Int
Glavni autori: Capitani, Nagaja, Lori, Giulia, Paoli, Paolo, Patrussi, Laura, Troilo, Arianna, Baldari, Cosima T., Raugei, Giovanni, D’Elios, Mario Milco
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Primary Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429822/
https://ncbi.nlm.nih.gov/pubmed/30948927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0786-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items